The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Lenalidomide Grindeks 10 mg hard capsules

AS GrindeksPA22992/004/004

Main Information

Trade NameLenalidomide Grindeks 10 mg hard capsules
Active SubstancesLenalidomide
Dosage FormCapsule, hard
Licence HolderAS Grindeks
Licence NumberPA22992/004/004

Group Information

ATC CodeL04AX04 lenalidomide


License statusAuthorised
Licence Issued03/12/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListLenalidomide 10mg Capsules
Interchangeable List CodeIC0125-002-001
Interchangeable List DocumentPDF of Interchangeable List
« Back